Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2193]
News [4500]
Articles [112]
Editorials [23]
Conferences [171]
elearning [18]
Comment: Kidney surgery may be unneeded in many intermediate-risk patients
Dr Sumanta Pal & Prof Richard Schilsky
Comment: Kidney surgery may be unneeded in many intermediate-risk patients ( Dr Sumanta Pal & Prof Richard Schilsky )
3 Jun 2018
Genetic testing of early breast tumours could allow patients to go without chemo
Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA
Genetic testing of early breast tumours could allow patients to go without chemo ( Dr Joseph Sparano - Albert Einstein Cancer Center, New York, USA )
3 Jun 2018
Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy
Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy
Paediatric rhabdomyosarcoma survival extended with maintenance chemotherapy ( Dr Gianni Bisogno - University Hospital of Padova, Padova, Italy )
3 Jun 2018
Kidney surgery may be unneeded in many intermediate-risk patients
Prof Arnaud Mejean - Paris Descartes University, Paris, France
Kidney surgery may be unneeded in many intermediate-risk patients ( Prof Arnaud Mejean - Paris Descartes University, Paris, France )
3 Jun 2018
ASCO 2018: Latest in bladder cancer treatments
Prof Thomas Powles & Prof Shahrokh Shariat
ASCO 2018: Latest in bladder cancer treatments ( Prof Thomas Powles & Prof Shahrokh Shariat )
3 Jun 2018
ASCO 2018: Integrating genomic data throughout treatment for prostate cancer
Prof Kurt Miller and Prof Bertrand Tombal
ASCO 2018: Integrating genomic data throughout treatment for prostate cancer ( Prof Kurt Miller and Prof Bertrand Tombal )
2 Jun 2018
A multi-histology basket trial of ado-trastuzumab emtansine in patients with...
Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA
A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers ( Dr Bob Li - Memorial Sloan Kettering Cancer Center, New York, USA )
2 Jun 2018
What will we expect from novel therapies for oesophageal and gastric...
Prof Ramon De Mello - University of Algarve, Faro, Portugal
What will we expect from novel therapies for oesophageal and gastric malignancies? ( Prof Ramon De Mello - University of Algarve, Faro, Portugal )
2 Jun 2018
Immunotherapy trials and hyperprogressive disease
Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain
Immunotherapy trials and hyperprogressive disease ( Dr Elena Garralda - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )
2 Jun 2018
The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for...
Prof William Wierda - MD Anderson Cancer Center, Houston, USA
The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for CLL patients ( Prof William Wierda - MD Anderson Cancer Center, Houston, USA )
2 Jun 2018
Development of blood tests for early lung cancer
Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA
Development of blood tests for early lung cancer ( Dr Geoffrey Oxnard - Dana-Farber Cancer Institute, Boston, USA )
2 Jun 2018
Matching personalised therapies to patients in the IMPACT trial
Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA
Matching personalised therapies to patients in the IMPACT trial ( Prof Apostolia Maria Tsimberidou - MD Anderson Cancer Center, Houston, USA )
2 Jun 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation